Reactome | SUMOylation of NFKBIA with SUMO1

SUMOylation of NFKBIA with SUMO1

Stable Identifier

R-HSA-4656914

Type

Reaction [transition]

Species

Homo sapiens

Compartment

nucleoplasm

ReviewStatus

5/5

Locations in the PathwayBrowser

Expand all

General

SBML | | PDF

SVG | | PPTX | SBGN

Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

NFKBIA (IKBA, IkappaBalpha) is SUMOylated at lysine-21 with SUMO1 (Desterro et al. 1998, Rodriguez et al. 2001, Liu et al. 2009). SUMOylation blocks ubiquitin-mediated proteolysis of NFKBIA and thereby inhibits NF-kappaB dependent transcription and acts as an anti-inflammatory. Adenosine signaling increases SUMOylation of NFKBIA with SUMO1. Nuclear import of NFKBIA is required for SUMOylation.

Literature References

PubMed ID	Title	Journal	Year
19297320	Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation Liu, Q, Colgan, SP, Khoury, J, Ibla, JC, Li, J	J. Biol. Chem.	2009
11124955	SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting Rodriguez, MS, Dargemont, C, Hay, RT	J. Biol. Chem.	2001
9734360	SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation Desterro, JM, Rodriguez, MS, Hay, RT	Mol. Cell	1998